Kinshasa: Confirmed Ebola cases in the Democratic Republic of the Congo have reached 1,708, including 580 deaths, health authorities said in a statement today. According to Oman News Agency, the WHO announced last Thursday that it had launched a clinical trial of two treatments for the rare Bundibugyo strain of the virus as the outbreak accelerates. "The clinical trial to evaluate two treatments has begun, with the first patient enrolled," WHO Director-General Tedros Adhanom Ghebreyesus told a press conference. The trial, under the name "Partners," will assess a monoclonal antibody and an antiviral drug, both individually and in combination. The study is managed by the National Institute for Biomedical Research in the DR Congo, with support from the WHO and other partners.
Related Articles
Gold Eases as Russia-Ukraine Ceasefire Optimism Curbs Safe-Haven Demand
Muscat: Gold prices today eased, as a slightly firmer dollar and optimism over a potential ceasefire between Russia and Ukraine dampened investor demand for safe-haven assets. Spot gold was down 0.5% at $3,213.35 an ounce. US gold futures slipped 0.6%…
Ebola Death Toll in DR Congo Nears 1,000 as Outbreak Spreads to Displacement Camps
Muscat: The Ebola death toll in the Democratic Republic of the Congo has risen to 967, with confirmed cases reaching 2,423 after 79 new infections were recorded in Ituri and North Kivu provinces, according to the National Institute of Public Health.
…
Bangladesh Battles Worst Measles Outbreak on Record
Muscat: Bangladesh, once on the verge of eliminating measles, is now facing its worst outbreak in history, with 999 suspected and confirmed measles-related deaths since March, as hospitals grapple with overcrowding, resource shortages, and a relentles…